文献速递小儿神经外科与脑积水

脑室腹腔分流术后药物性血栓预防:单中心血栓栓塞与出血结局

Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes.
PubMed 文献 · Acta Neurochir (Wien) · 2026-07-29

本研究回顾性纳入2017至2021年在一家三级中心接受初次脑室腹腔分流术的246例成人患者,评估术后药物性血栓预防与静脉血栓栓塞及血肿风险的关系。76.0%患者接受药物性血栓预防(中位术后第1天),仅1例(0.4%)发生肺栓塞,12例(4.9%)发现血肿,其中2例(0.8%)有临床意义;药物性血栓预防未显著增加血肿风险(p > 0.99),倾向性评分匹配亚组分析结果一致(p = 0.36)。

要点

  • 初次脑室腹腔分流术后早期药物性血栓预防(中位术后第1天)在成人中安全性可接受。
  • 术后常规影像检出12例血肿(4.9%),仅2例(0.8%)有临床意义。
  • 药物性血栓预防未显著增加术后血肿风险(总体p > 0.99,匹配亚组p = 0.36)。

核心结论

  • 初次脑室腹腔分流术后早期药物性血栓预防似乎安全性可接受,未显著增加血肿风险。
  • 研究结果需在未来多中心队列中验证。

研究设计与样本

  • 回顾性队列研究,纳入2017至2021年一家三级中心接受初次脑室腹腔分流术的246例成人患者。
  • 收集人口学、病因、手术、影像、药物性血栓预防及结局(静脉血栓栓塞、术后血肿)数据。
  • 采用单变量分析和倾向性评分匹配比较结局。

主要发现

  • 中位年龄63岁(范围17-90岁),常见脑积水病因为肿瘤(32.9%)和正常压力脑积水(30.5%)。
  • 76.0%(n = 187)接受药物性血栓预防(中位术后第1天),并普遍使用机械预防。
  • 发生1例静脉血栓栓塞事件(肺栓塞,0.4%)。
  • 常规术后影像检出12例血肿(4.9%),其中2例(0.8%)有临床意义:1例脑出血需手术清除,1例保守治疗。
  • 药物性血栓预防未显著增加术后血肿形成风险(总体p > 0.99;倾向性评分匹配亚组p = 0.36)。

临床怎么用

  • 对于接受初次脑室腹腔分流术的成人,可考虑术后早期启动物质性血栓预防,但需结合个体出血风险评估。
  • 术后应关注血肿风险,尤其是有临床意义的血肿(本研究中0.8%)。

局限性

  • 单中心回顾性设计。
  • 结果需多中心队列验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a risk in neurosurgery, but data for adults undergoing ventriculoperitoneal (VP) shunt insertion are limited. The safety of post-operative pharmacological thromboprophylaxis in this population remains unclear due to concerns about bleeding. This study evaluated the safety of post-operative pharmacological thromboprophylaxis after VP shunt insertion in adults in relation to VTE and haematoma risk. METHODS: This retrospective cohort study included 246 adult patients who underwent primary VP shunt insertion at a tertiary centre between 2017 and 2021. Data on demographics, aetiology, surgery, radiological imaging, pharmacological thromboprophylaxis, and outcomes (VTE, post-operative haematomas) were collected and reviewed. Univariate analysis and propensity-matching were used to compare outcomes. RESULTS: Median age was 63 years (range 17-90 years); common hydrocephalus aetiologies were tumour (32.9%) and normal pressure hydrocephalus (30.5%). Pharmacological thromboprophylaxis (median post-operative day 1) was given to 76.0% (n = 187), alongside universal mechanical prophylaxis. One VTE (pulmonary embolism, 0.4%) event occurred. Routine post-operative imaging detected 12 haematomas (4.9%); 2 (0.8%) were clinically significant: 1 intracerebral haemorrhage requiring surgical evacuation and 1 managed conservatively. Pharmacological thromboprophylaxis did not significantly increase the risk of post-operative haematoma formation overall (p > 0.99) and in a propensity score matched subgroup analysis that controlled for confounders (p = 0.36). CONCLUSION: In this study, we demonstrate that early pharmacological thromboprophylaxis after primary VP shunt insertion appears to have an acceptable safety profile without significantly increasing haematoma risk. Our findings require validation in future multicentre cohorts.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Alnaser, Zurel, Alnsour, et al. Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes. Acta Neurochir (Wien). 2026. PMID: 42934435. doi:10.1007/s00701-026-06923-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。